Bile Duct Cancer - 42 Studies Found
| Recruiting |
: RFA RCT for Pancreatic or Bile Duct Cancer :
: 2014-06-11 :
|
| Active, not recruiting |
: Fatigue and Pancreas and Bile Duct Cancer Study : Pancreatic Cancer : 2009-05-13 : Other: Walking Program "Brisk" walking is defined as faster than the slow walk, but not to exh |
| Recruiting |
: Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy :
|
| Completed |
: Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction :
|
| Completed |
: Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer :
: |
| Completed |
: A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases :
: 2007-10-09 : Drug: EndoTAG®-1 EndoTAG®-1 22 mg/m² twice weekly |
| Withdrawn |
: Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma :
|
| Completed |
: Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer :
|
| Recruiting |
: Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer :
|
| Terminated |
: Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer :
: 2011-01-22 : |